Charles Schwab’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-199,901
| Closed | -$130K | – | 3572 |
|
2025
Q1 | $130K | Sell |
199,901
-52,094
| -21% | -$33.9K | ﹤0.01% | 3307 |
|
2024
Q4 | $464K | Hold |
251,995
| – | – | ﹤0.01% | 3161 |
|
2024
Q3 | $872K | Buy |
251,995
+35,167
| +16% | +$122K | ﹤0.01% | 2958 |
|
2024
Q2 | $635K | Buy |
216,828
+55,952
| +35% | +$164K | ﹤0.01% | 3094 |
|
2024
Q1 | $909K | Hold |
160,876
| – | – | ﹤0.01% | 2819 |
|
2023
Q4 | $690K | Hold |
160,876
| – | – | ﹤0.01% | 2958 |
|
2023
Q3 | $558K | Hold |
160,876
| – | – | ﹤0.01% | 3006 |
|
2023
Q2 | $748K | Buy |
160,876
+14,936
| +10% | +$69.5K | ﹤0.01% | 2871 |
|
2023
Q1 | $674K | Buy |
145,940
+1,793
| +1% | +$8.28K | ﹤0.01% | 2854 |
|
2022
Q4 | $1.16M | Buy |
144,147
+12,942
| +10% | +$105K | ﹤0.01% | 2727 |
|
2022
Q3 | $729K | Buy |
131,205
+11,422
| +10% | +$63.5K | ﹤0.01% | 2892 |
|
2022
Q2 | $625K | Buy |
119,783
+116
| +0.1% | +$605 | ﹤0.01% | 2981 |
|
2022
Q1 | $984K | Buy |
119,667
+10,118
| +9% | +$83.2K | ﹤0.01% | 2854 |
|
2021
Q4 | $1.63M | Buy |
109,549
+1,676
| +2% | +$25K | ﹤0.01% | 2765 |
|
2021
Q3 | $2.04M | Buy |
107,873
+3,875
| +4% | +$73.2K | ﹤0.01% | 2700 |
|
2021
Q2 | $1.93M | Buy |
103,998
+22,600
| +28% | +$420K | ﹤0.01% | 2723 |
|
2021
Q1 | $1.85M | Buy |
81,398
+11,173
| +16% | +$254K | ﹤0.01% | 2684 |
|
2020
Q4 | $1.53M | Buy |
70,225
+4,366
| +7% | +$94.8K | ﹤0.01% | 2675 |
|
2020
Q3 | $662K | Buy |
65,859
+17,628
| +37% | +$177K | ﹤0.01% | 2801 |
|
2020
Q2 | $375K | Buy |
48,231
+25,639
| +113% | +$199K | ﹤0.01% | 2948 |
|
2020
Q1 | $231K | Hold |
22,592
| – | – | ﹤0.01% | 2970 |
|
2019
Q4 | $249K | Hold |
22,592
| – | – | ﹤0.01% | 3010 |
|
2019
Q3 | $206K | Hold |
22,592
| – | – | ﹤0.01% | 3037 |
|
2019
Q2 | $258K | Buy |
22,592
+9,482
| +72% | +$108K | ﹤0.01% | 3052 |
|
2019
Q1 | $150K | Hold |
13,110
| – | – | ﹤0.01% | 3060 |
|
2018
Q4 | $119K | Buy |
+13,110
| New | +$119K | ﹤0.01% | 3079 |
|